Intravenous alpha-1 antitrypsin augmentation therapy: Systematic review

Danish Medical Bulletin

Volumn 57, Issue 9, 2010, Pages

  Gøtzsche, Peter C ^a   Johansen, Helle Krogh ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CARBON MONOXIDE; PLACEBO; TRYPSIN INHIBITOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; CHRONIC OBSTRUCTIVE LUNG DISEASE; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; INJECTIONS, INTRAVENOUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPSIN INHIBITORS;

EID: 77957659757     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Alpha-1 antitrypsin deficiency. US National Library of Medicine. http://ghr.nlm.nih.gov/condition=alpha1antitrypsindeficiency 2007 (16 November 2008).
2. O'Brien ML, Buist NR, Murphey WH. Neonatal screening for alpha1- antitrypsin deficiency. J Pediatrics 1978;92:1006-10.
3. Sveger T. Alpha1-antitrypsin deficiency in early childhood. Pediatrics 1978;62:22-5.
4. Evald T, Dirksen A, Keittelmann S et al. Decline in pulmonary function in patients with alpha-1-antitrypsin deficiency. Lung 1990;168(Suppl):579-85.
5. Hutchison DCS. Natural history of alpha1-protease inhibitor deficiency. Am J Med 1988;84(Suppl 6A):3-12.
6. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204:345-51.
7. Sharp HL. Alpha-one-antitrypsin deficiency. Hospital Practice 1971;6:83-96.
8. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21.
9. Shah P, Ohlsson A. Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001;(3): CD002775.
10. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
11. Higgins JPT, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
12. Dirksen A, Dijkman JH, Madsen F et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Resp Crit Care Med 1999;160:1468-72.
13. Dirksen A, Piitulainen E, Parr DG et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha-1 antitrypsin deficiency. Eur Resp J 2009;33:1345-53.
14. www.clinicaltrials.gov. NCT00261833 2006 (7 January 2010).
15. Silverman EK, Sandhaus RA. Alpha1-antitrypsin deficiency. N Engl J Med 2009;360:2749-57.
16. Chen S, Farahati F, Marciniuk D et al. Human α1-proteinaseinhibitor for patients with α1-antitrypsin deficiency (Technology report no 74). Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007.
17. Heresi GA, Stoller JK. Augmentation therapy in α-1 antitrypsin deficiency. Exp Opin Biol Ther 2008;8:515-26.
18. Stockley RA, Deng C, Piitulainen E et al. Therapeutic efficacy of Alpha-1 Antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis [abstract]. In: American Thoracic Society International Conference, May 16-21, 2008, Toronto. 2008:A419[#D49].